Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4953286 | 0.82 | KCNN4 (0.58) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL4955974 | 0.78 | KCNN4 (0.62) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL27382896 | 0.77 | KCNN4 (0.60) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL4014494 | 0.77 | KCNN4 (0.60) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL21659699 | 0.77 | KCNN4 (0.60) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL11228441 | 0.77 | KCNN4 (0.60) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL16732336 | 0.77 | POLB (0.61) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL4965119 | 0.76 | KCNN4 (0.55) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL8410004 | 0.76 | KCNN4 (0.55) | KCNN4SRCNR1H2NR1H3CYP2C19 | |
| SCHEMBL10982127 | 0.75 | KCNN4 (0.58) | KCNN4SRCNR1H2NR1H3CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10006151-B2 | Polyurethane fiber | TORAY OPELONTEX CO., LTD. (JP) | 2018-06-26 | — | — | US | disclosed |
| EP-2947185-B1 | POLYURETHANE FIBER AND ITS USE | TORAY OPELONTEX CO LTD (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-20160002827-A1 | POLYURETHANE FIBER | TORAY OPELONTEX CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2947185-A1 | POLYURETHANE FIBER | Toray Opelontex Co., Ltd (JP) | 2015-11-25 | — | — | EP | disclosed |
| US-20080221003-A1 | CONSUMER PRODUCTS HAVING VARYING ODOR PATTERNS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080207481-A1 | CONSUMER PRODUCTS HAVING VARYING ODORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-08-28 | — | — | US | disclosed |
| US-20080207476-A1 | PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207476-A1 | PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES | DSC1, DSG1, PIEZO1 | KCNN4 1617/4885SRC 3324/4885NR1H2 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.